Literature DB >> 27789520

Omega-3 polyunsaturated fatty acids promote amyloid-β clearance from the brain through mediating the function of the glymphatic system.

Huixia Ren1, Chuanming Luo2, Yanqing Feng3, Xiaoli Yao3, Zhe Shi1, Fengyin Liang2, Jing X Kang4, Jian-Bo Wan1, Zhong Pei3, Huanxing Su5.   

Abstract

Impairment of amyloid-β (Aβ) clearance leads to Aβ accumulation in the brain during the development of Alzheimer's disease (AD). Strategies that can restore or improve the clearance function hold great promise in delaying or preventing the onset of AD. Here, we show that n-3 polyunsaturated fatty acids (PUFAs), by use of fat-1 transgenic mice and oral administration of fish oil, significantly promote interstitial Aβ clearance from the brain and resist Aβ injury. Such beneficial effects were abolished in Aqp4-knockout mice, suggesting that the AQP4-dependent glymphatic system is actively involved in the promoting the effects of n-3 PUFAs on the clearance of extracellular Aβ. Imaging on clarified brain tissues clearly displayed that n-3 PUFAs markedly inhibit the activation of astrocytes and protect the AQP4 polarization in the affected brain region after Aβ injection. The results of the present study prove a novel mechanism by which n-3 PUFAs exert protective roles in reducing Aβ accumulation via mediating the glymphatic system function.-Ren, H., Luo, C., Feng, Y., Yao, X., Shi, Z., Liang, F., Kang, J. X., Wan, J.-B., Pei, Z., Su, H. Omega-3 polyunsaturated fatty acids promote amyloid-β clearance from the brain through mediating the function of the glymphatic system. © FASEB.

Entities:  

Keywords:  AQP4 polarization; DHA; extracellular solutes clearance; fish oil; perivascular pathways

Mesh:

Substances:

Year:  2016        PMID: 27789520     DOI: 10.1096/fj.201600896

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  23 in total

Review 1.  The glymphatic system: implications for drugs for central nervous system diseases.

Authors:  Terhi J Lohela; Tuomas O Lilius; Maiken Nedergaard
Journal:  Nat Rev Drug Discov       Date:  2022-08-10       Impact factor: 112.288

Review 2.  The meningeal lymphatic vessels and the glymphatic system: Potential therapeutic targets in neurological disorders.

Authors:  Gaowei Li; Yi Cao; Xin Tang; Jianhan Huang; Linjun Cai; Liangxue Zhou
Journal:  J Cereb Blood Flow Metab       Date:  2022-04-28       Impact factor: 6.960

3.  Chronic stress impairs the aquaporin-4-mediated glymphatic transport through glucocorticoid signaling.

Authors:  Fang Wei; Jian Song; Cui Zhang; Jun Lin; Rong Xue; Li-Dong Shan; Shan Gong; Guo-Xing Zhang; Zheng-Hong Qin; Guang-Yin Xu; Lin-Hui Wang
Journal:  Psychopharmacology (Berl)       Date:  2019-01-03       Impact factor: 4.530

Review 4.  The glymphatic pathway in neurological disorders.

Authors:  Martin Kaag Rasmussen; Humberto Mestre; Maiken Nedergaard
Journal:  Lancet Neurol       Date:  2018-11       Impact factor: 44.182

Review 5.  Glymphatic System Impairment in Alzheimer's Disease and Idiopathic Normal Pressure Hydrocephalus.

Authors:  Benjamin C Reeves; Jason K Karimy; Adam J Kundishora; Humberto Mestre; H Mert Cerci; Charles Matouk; Seth L Alper; Iben Lundgaard; Maiken Nedergaard; Kristopher T Kahle
Journal:  Trends Mol Med       Date:  2020-01-18       Impact factor: 11.951

Review 6.  Waste Clearance in the Brain.

Authors:  Jasleen Kaur; Lara M Fahmy; Esmaeil Davoodi-Bojd; Li Zhang; Guangliang Ding; Jiani Hu; Zhenggang Zhang; Michael Chopp; Quan Jiang
Journal:  Front Neuroanat       Date:  2021-07-07       Impact factor: 3.856

Review 7.  The Glymphatic System: A Novel Component of Fundamental Neurobiology.

Authors:  Lauren M Hablitz; Maiken Nedergaard
Journal:  J Neurosci       Date:  2021-09-15       Impact factor: 6.167

Review 8.  Significance of long chain polyunsaturated fatty acids in human health.

Authors:  Rafael Zárate; Nabil El Jaber-Vazdekis; Noemi Tejera; José A Pérez; Covadonga Rodríguez
Journal:  Clin Transl Med       Date:  2017-07-27

9.  Voluntary Exercise Promotes Glymphatic Clearance of Amyloid Beta and Reduces the Activation of Astrocytes and Microglia in Aged Mice.

Authors:  Xiao-Fei He; Dong-Xu Liu; Qun Zhang; Feng-Ying Liang; Guang-Yan Dai; Jin-Sheng Zeng; Zhong Pei; Guang-Qing Xu; Yue Lan
Journal:  Front Mol Neurosci       Date:  2017-05-19       Impact factor: 5.639

10.  Efficacy and Blood Plasmalogen Changes by Oral Administration of Plasmalogen in Patients with Mild Alzheimer's Disease and Mild Cognitive Impairment: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial.

Authors:  Takehiko Fujino; Tatsuo Yamada; Takashi Asada; Yoshio Tsuboi; Chikako Wakana; Shiro Mawatari; Suminori Kono
Journal:  EBioMedicine       Date:  2017-02-24       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.